Sodium Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 3, 2016.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-3299-05
- Dosage Form
- Injection
- Presentation
- Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)
- Initial Posting
- Feb 3, 2016